hims personalized semaglutide Affordability and Safety: How & Hers is Delivering a New GLP-1 Experience Through the Scale of Our Platform Full Range of FDA-Approved GLP-1s

A study from the University of Pennsylvania and Cedars-Sinai Medical Center found a 700% increase in use of the drugs for patients without diabetes from 2019 to 2023

References Abdalrahman SS, Smail HO, Shallal AF

Adderall, a combination amphetamine salt formulation, increases dopamine and norepinephrine activity in the central nervous system, enhancing focus and attention while also suppressing appetite as a side effect

In addition, all currently available GLP-1R therapies are peptide agonists, most of which require subcutaneous administration [140]

But the hype around this class of drugs is not just limited to these indications